Navigation Links
Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert
Date:11/5/2009

latility in foreign exchange rates, the uncertainty of market acceptance of new product introductions, the uncertainty of gaining new strategic relationships or locating and capitalizing on strategic opportunities, the uncertainty of timing of private label sales revenues (particularly international customers), FDA and other regulatory review and response times, and other risk factors listed from time to time in the Company's SEC reports and filings, including, without limitation, the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended September 30, 2008 and subsequent reports on Forms 10-Q and 8-K. Readers are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

The Company will hold a quarterly conference call to discuss its earnings report. The call will begin at 3:30 p.m. central time (4:30 p.m. eastern time).

This call is being webcast by Thomson/CCBN and can be accessed at Rochester Medical's website at www.rocm.com. To listen live to the conference call via telephone, call:

    Domestic:         888.680.0893
    International:    617.213.4859
    Pass code:        64235793
    Pre Registration:
     https://www.theconferencingservice.com/prereg/key.process?key=PD8MG6W7Q
    Replay will be available for seven days at www.rocm.com
     or via telephone at:
    Domestic:         888-286-8010
    International:    617-801-6888
    Pass code:        31548516

Individual investors can listen to the call at www.fulldisclosure.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-prote
'/>"/>

SOURCE Rochester Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Rochester Medical Announces Fourth Quarter 2009 Earnings Conference Call Thursday, November 5th 2009
2. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
3. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
4. Symmetry Medical Reports Third Quarter 2009 Financial Results
5. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
6. Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products
7. ATS Medical to Participate in the 2009 Canaccord Adams Cardiovascular Conference
8. CMS Admits New Surety Bond and Accreditation Requirement for Home Medical Equipment Suppliers Creating Patient Access Issues
9. AACE Issues New Medical Guidelines for Proper and Ethical Use of Growth Hormone
10. Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and "Arthritis Kits"
11. Medical Imaging Solutions Firm Dicom Solutions Ranks No. 109 on the Inc. 500

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e/-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/...ctiveRandomizedOralTherapyEvaluationinCrohn,sdisea...oderate-to-severeCrohn,sdiseasedemonstratedclinica...e.Thestudydemonstratedevidenceofclinicalefficacyin...ecreaseintheCrohn,sDiseaseActivityIndex(CDAI)inpat...
(Date:11/24/2009)..., WHAT:RomHoubens,aBelgianmanthoughttohavebeeninco...lyconsciousandawakeduringthattimeandwasthesubjecto...turedinthesegmenttoillustratehowpeoplewithLocked-i... ,, WHEN:GoodMorningAmerica-- Tuesday,November2..., WHO:RomHoubenswasanengineeringstudentin1986when...
(Date:11/24/2009)...Call/--QuestDiagnosticsIncorporated(NYSE: DGX ),th...tionandservices,announcedthatitisscheduledtospeaka...wYorkCity.ThepresentationisscheduledforWednesday,D...econference,thecompanywillreaffirmits2009guidancef...ceed18%ofrevenues,anddilutedearningspersharefromco...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 1 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 2 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 3 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 4 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 5 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 6AlphaHelix Presents AmpXpress 28TM 29 at the BIOTECHNICA Show 14356 1AlphaHelix Presents AmpXpress 28TM 29 at the BIOTECHNICA Show 14356 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 1US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 3
...orporation (Nasdaq:,DNDN) today will present a sum...uleucel-T), an investigational active cellular imm...um in New York City. The presentation, which,integ...s the safety,profile, immune response and clinical...sitive cancer who have failed standard therapy., ...
...Pharmaceuticals,Inc. (Nasdaq: VIAP ), a biotechno...ds for the treatment of cardiovascular disease, an...and webcast to discuss results of the,VIA-2291 Pha...arterectomy,(CEA) trials presented at the American...on Sunday, November 9. The conference call and web...
Other Medicine Technology:Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 2Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 3Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 4VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA 2
(Date:11/25/2009)...ovementShownforthe4thStraightYear ,, WASHINGT...erAlliance-Georgia(LCA-GA)issuedthe 4thAnnualRepor...essbeingmadeagainstthislethaldiseaseinthestateofGe...eonlynationalorganizationdedicatedexclusivelytopat...orlungcancer. ,, (Logo: http://www.newscom.com/...
(Date:11/25/2009)...at colorectal cancer also can reverse a rare stoma...erapy for the disease, researchers at Vanderbilt U...ier,s disease causes thickening of the stomach lin...s well as anemia and swelling in the feet and ankl...risk for gastric cancer. Previously, the only effe...
(Date:11/25/2009)...d under the skin kill tumor cells, study finds , ...A cancer vaccine delivered in a fingernail-size im...udy reports. , The method uses polymer disks, 8...umor-specific antigens and implanted under the ski... The Harvard University scientists who developed t...
(Date:11/25/2009)... Nationwide Imaging Services, known as one of...iagnostic imaging equipment, now offering a total ...cing options, service and installation with acquis...echnologies of California) , ...ide Imaging Services is proud to announce its acqu...
(Date:11/25/2009)... BioSpace.com, the premier resource for life ...d edition of the BioForest™ Hotbed Campaign ..., CO (Vocus) November 25, 2009 -- BioSpace.com, th...formation, unveiled the third edition of the BioFo...,This regional campaign is a promotional effort hi...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...travenous antiviral drug may be helpful in easing ... which is caused by varicella-zoster virus, is a p...ports that researchers at the University of Colora...ts received 10 milligrams of the drug acyclovir in...
... a high degree of comfort level in ethnically dive...re safer// , and make the students feel wanted. St...ared to other schools. Psychologists from UCLA ...rity of low-income students who belong to the mino...
...f food poisoning, now has a new remedy, which is s... working at the University of Bristol//. The fin...esearchers have narrowed down on a particular anti...ed for the treatment of listeriosis, in spite of i...
...d that there is a need for more talking therapies ... has planned to announce the sites of two talking ...ed at cognitive behavioural therapy (CBT) in help...ts helpline callers show 83% take medication while...
...ties seem to eat healthy food compared to their pe...//. Teenage girls who participate in weight-re...stics and wrestling are more likely to eat breakfa...r team sports. The results of this present study c...
...red by scientists at UCSF, Celera Genomics and The...reased risk// for early heart attack, or myocardia...VAMP8, normally expresses a protein essential for ...ack risk can help identify people at risk and clar...
Other Medicine News:Health News:Comfort Level, Maximum in Ethnically Diverse Schools 2Health News:Comfort Level, Maximum in Ethnically Diverse Schools 3Health News:Gene Variants Linked to Early Heart Attack Discovered 2Health News:Gene Variants Linked to Early Heart Attack Discovered 3Health News:Gene Variants Linked to Early Heart Attack Discovered 4
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: